MediPharm Labs Corp. (LABS) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medipharm Labs Corp..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.735 Thank you for standing by and welcome to the MediPharm Labs conference call to discuss 00:00:03.735 -- 00:00:06.659 the second quarter 2025 results. 00:00:06.659 -- 00:00:10.664 Our speakers on today's call are David Piddock, President and Chief Executive Officer, 00:00:10.664 -- 00:00:15.490 and Greg Hunter, Chief Financial Officer. As a reminder, all participants are in the 00:00:15.490 -- 00:00:18.774 listen-only mode and the conference is being recorded. 00:00:18.774 -- 00:00:22.598 After management's presentation, we will take written questions through the Q&A feature 00:00:22.598 -- 00:00:24.520 on the webcast. 00:00:24.520 -- 00:00:28.105 The information contained on this presentation should be considered together with the 00:00:28.105 -- 00:00:32.237 more detailed information, disclosure, financial data and statements available on the 00:00:32.237 -- 00:00:35.441 company's website and on CDR Plus profile. 00:00:35.441 -- 00:00:40.087 As seen on slide two and three, I would like to note that this earnings call contains 00:00:40.087 -- 00:00:44.613 forward-looking information and is based on the company's current expectations, estimates, 00:00:44.613 -- 00:00:49.740 and beliefs as of today's date, and will also use terms that are non-IFRS financial 00:00:49.740 -- 00:00:51.262 measures. 00:00:51.262 -- 00:00:55.007 Please review the company's most recent disclosure material for the risks associated 00:00:55.007 -- 00:00:59.566 with the use of forward-looking information and the use of non-IFRS financial measures 00:00:59.566 -- 00:01:01.468 in this presentation. 00:01:01.468 -- 00:01:05.793 Please note that all dollar amounts mentioned in today's call are in Canadian dollars 00:01:05.793 -- 00:01:09.277 unless otherwise noted...